HIV Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Test Type (Screening, Differentiation & Confirmation Test, and Monitoring Test), by End User (Hospital and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and

HIV Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Test Type (Screening, Differentiation & Confirmation Test, and Monitoring Test), by End User (Hospital and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Acquired Immunodeficiency Syndrome (AIDS) is caused by human immunodeficiency virus (HIV). HIV diagnosis tests are carried out to detect the presence of the virus. HIV diagnosis can be performed by blood test, saliva test, viral load test, though the most efficient test results are achieved by Enzyme Linked Immunosorbent Assay (ELISA) test initially and Western Bloat Method. ELISA test, which is enzyme linked immunosorbent assay, uses the antibodies to identify the substance and the western blot technique is used to detect anti –HIV antibodies in the human serum sample.

Market Dynamics

Increasing prevalence of HIV are expected to propel global demand for HIV diagnostics over the forecast period. For instance, according to the UNAIDS 2019 report, number of HIV cases increased from 37.2 million to around 37.9 million globally, from the year 2017 and 2018 respectively. Moreover, according to the UNAIDS 2019 report, around 1.7 million new cases of people globally living with HIV was reported in 2018.

Increasing collaborations and acquisitions by the market players are expected to drive the market growth over the forecast period. For instance, in 2016, Abbott Laboratories acquired Alere Inc, a manufacturer of rapid point-of-care diagnostic tests. The acquisition was done to add tests products for infectious diseases such as HIV, tuberculosis, malaria, influenza to Abbott Laboratories’ suite of products for testing genetic mutations and to boost diagnostics offerings of the company.

Moreover, rising product launches by the market players is expected to propel the market growth over the forecast period. For instance, in 2014, BD Biosciences, a segment of BD (Becton, Dickinson and Company) launched BD FACSPresto near patient CD4 counter system for HIV/AIDS patients, which provide lymphocytes and hemoglobin (Hb) concentration in blood samples to stage and monitor HIV/AIDS patients. Moreover, in July 2017, bioLytical Laboratories launched INSTI HIV Self-Test in pharmacies across the Netherlands, thereby providing access to HIV tests for early diagnosis. The INSTI product line is 99% accurate and provides test results in 60 seconds or less. Moreover, the company also offers contract services to adapt the INSTI platform to meet custom functional and technical diagnostic testing requirements.

Key features of the study:

  • This report provides in-depth analysis of the HIV diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global HIV diagnostics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as part of this study include Abbott Laboratories, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol –Myres Squibb, Janssen Therapeutic, QIAGEN N.V., and ViiV Healthcare Ltd
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
  • The global HIV diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the HIV diagnostics market
Detailed Segmentation:
  • Global HIV Diagnostics Market, By Product Type:
  • Instruments
  • Reagents & Kits
  • Global HIV Diagnostics Market, By Test Type:
  • Screening
  • Third Generation (Antibody Test)
  • Laboratory-based
  • Point-of-Care
  • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
  • Laboratory-based
  • Point-of-Care
  • Others
  • Differentiation & Confirmation Test
  • Monitoring Test
  • CD4 Tests
  • Viral Load Tests
  • Global HIV Diagnostics Market, By End User:
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others
  • Global HIV Diagnostics Market, By Region:
  • North America
  • By Product Type:
  • Instruments
  • Reagents & Kits
  • By Test Type:
  • Screening
  • Third Generation (Antibody Test)
  • Laboratory-based
  • Point-of-Care
  • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
  • Laboratory-based
  • Point-of-Care
  • Others
  • Differentiation & Confirmation Test
  • Monitoring Test
  • CD4 Tests
  • Viral Load Tests
  • By End User:
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Product Type:
  • Instruments
  • Reagents & Kits
  • By Test Type:
  • Screening
  • Third Generation (Antibody Test)
  • Laboratory-based
  • Point-of-Care
  • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
  • Laboratory-based
  • Point-of-Care
  • Others
  • Differentiation & Confirmation Test
  • Monitoring Test
  • CD4 Tests
  • Viral Load Tests
  • By End User:
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Product Type:
  • Instruments
  • Reagents & Kits
  • By Test Type:
  • Screening
  • Third Generation (Antibody Test)
  • Laboratory-based
  • Point-of-Care
  • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
  • Laboratory-based
  • Point-of-Care
  • Others
  • Differentiation & Confirmation Test
  • Monitoring Test
  • CD4 Tests
  • Viral Load Tests
  • By End User:
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type:
  • Instruments
  • Reagents & Kits
  • By Test Type:
  • Screening
  • Third Generation (Antibody Test)
  • Laboratory-based
  • Point-of-Care
  • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
  • Laboratory-based
  • Point-of-Care
  • Others
  • Differentiation & Confirmation Test
  • Monitoring Test
  • CD4 Tests
  • Viral Load Tests
  • By End User:
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product Type:
  • Instruments
  • Reagents & Kits
  • By Test Type:
  • Screening
  • Third Generation (Antibody Test)
  • Laboratory-based
  • Point-of-Care
  • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
  • Laboratory-based
  • Point-of-Care
  • Others
  • Differentiation & Confirmation Test
  • Monitoring Test
  • CD4 Tests
  • Viral Load Tests
  • By End User:
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type:
  • Instruments
  • Reagents & Kits
  • By Test Type:
  • Screening
  • Third Generation (Antibody Test)
  • Laboratory-based
  • Point-of-Care
  • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
  • Laboratory-based
  • Point-of-Care
  • Others
  • Differentiation & Confirmation Test
  • Monitoring Test
  • CD4 Tests
  • Viral Load Tests
  • By End User:
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Abbott Laboratories*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • Siemens Healthineers
  • Roche AG
  • Beckman Coulter Inc.
  • OraSure Technologies, Inc.
  • Becton, Dickinson and Company
  • Merck KGaA
  • Chembio Diagnostic Systems, Inc.
  • Zyomyx Incorporation
  • Bristol –Myres Squibb
  • Janssen Therapeutic
  • QIAGEN N.V.
  • ViiV Healthcare Ltd
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Test Type
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Regulatory Scenario
Reimbursement Scenario
PEST Analysis
PORTER’s Analysis
Recent Product Launch
Merger and Acquisition Scenario
4. Global HIV Diagnostics Market, By Product Type, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Instruments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Reagents & Kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
5. Global HIV Diagnostics Market, By Test Type, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Screening
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Third Generation (Antibody Test)
Laboratory-based
Point-of-Care
Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
Laboratory-based
Point-of-Care
Others
Differentiation & Confirmation Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Monitoring Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
CD4 Tests
Viral Load Tests
6. Global HIV Diagnostics Market, By End User, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Hospital and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
7. Global HIV Diagnostics Market, By Region, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2019 and 2027 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2027
North America
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Abbott Laboratories
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bio-Rad Laboratories, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Hologic, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Siemens Healthineers
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Roche AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Beckman Coulter Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
OraSure Technologies, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Becton, Dickinson and Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck KGaA
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Chembio Diagnostic Systems, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Zyomyx Incorporation
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol –Myres Squibb
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Janssen Therapeutic
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
QIAGEN N.V.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
ViiV Healthcare Ltd
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
References
Research Methodology
About Us and Sales Contact
*Browse 34 market data tables and 25 figures on "HIV Diagnostics Market - Global forecast to 2027”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook